This study examined the prevalence and correlates of fibromyalgia and insomnia in a convenience sample of Women with Multiple Sclerosis (WMS).
Methods
The study was cross-sectional in design and recruited a sample of 163 women with Relapsing-Remitting Multiple Sclerosis (RRMS). Fibromyalgia was assessed using the Patient Self-Report Survey (PSRS), which follows criteria outlined by the American College of Rheumatology. Insomnia was measured using the Arabic version of the Insomnia Severity Index (ISI-A).
Results
The prevalence of fibromyalgia and insomnia was 28.2% (n = 46) and 46.3% (n = 76), respectively. Multivariate analyses were used to determine significant independent correlates. Fibromyalgia was associated with age above 40 years (OR = 2.29, 95% CI = 1.01-5.18, P = .04), high school education (OR = 3.69, 95% CI = 1.62-8.37, P = .002), and non-use of analgesics (OR = .02, 95% CI = .004-.21, P = .001). Insomnia symptoms were significantly associated only with age above 40 years (OR = 2.16, 95% CI = 1.16-4.04, P = .01).
Conclusion
These findings highlight the need for increased attention by primary care physicians towards diagnosing and treating fibromyalgia and insomnia among women with RRMS in Jordan, particularly for older women.
ThompsonAJBanwellBLBarkhofF, et al.Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
2.
NedjatSMontazeriAMohammadK, et al.Quality of life in multiple sclerosis compared to the healthy population in Tehran. Iran J Epidemiol. 2006;2(3):19-24.
3.
CliffordDBTrotterJL. Pain in multiple sclerosis. Arch Neurol. 1984;41(12):1270-1272.
4.
StenagerEKnudsenLJensenK. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand. 1991;84(3):197-200.
MarquesAPSantoAde Sdo EBerssanetiAAMatsutaniLAYuanSLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol English Ed. 2017;57(4):356-363.
8.
MarrieRAYuBNLeungS, et al.The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: a population-based study. Mult Scler Relat Disord [Internet]. 2012;1(4):162-167. Available from: DOI: 10.1016/j.msard.2012.06.001.
9.
ClemenziAPompaACasilloP, et al.Chronic pain in multiple sclerosis: is there also fibromyalgia? An observational study. Med Sci Mon Int Med J Exp Clin Res. 2014;20:758-766.
10.
UlusoyEK. Effects of comorbid fibromyalgia syndrome on activities of daily living in multiple sclerosis patients. Arq Neuropsiquiatr. 2020;78(9):556-560.
11.
PugliattiMSotgiuSRosatiG. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104(3):182-191.
12.
SiegertRJAbernethyD. Depression in multiple sclerosis: a review. J Neurol Neurosurg \& Psychiatry. 2005;76(4):469-475.
13.
WeirPTHarlanGANkoyFL, et al.The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. JCR J Clin Rheumatol. 2006;12(3):124-128.
14.
GammohOEnnabW. Depression, anxiety, insomnia and dysmenorrhoea in stressed fingolimod-treated women with multiple sclerosis. Int J Psychiatry Med. 2023;59:1-15.
15.
BamerAMJohnsonKLAmtmannDKraftGH. Prevalence of Sleep Problems in Individuals with Multiple Sclerosis. Mult Scler. 2008;14:1127-1130.
16.
DrerupMRothAKaneASullivanAB. Therapeutic approaches to insomnia and fatigue in patients with multiple sclerosis. Nat Sci Sleep. 2021;13:201.
17.
BurattiLIacobucciDEViticchiG, et al.Sleep quality can influence the outcome of patients with multiple sclerosis. Sleep Med. 2019;58:56-60.
18.
AldughmiMAl-ShormanAKhalilHEl-SalemKAlghwiriA. Translation and validation of the Arabic version of the patient determined disease steps in people with multiple sclerosis. Physiother Theory Pract. 2022;38(9):1281–1288. Available from: DOI: 10.1080/09593985.2020.1839988
19.
YunusMBArslanSAldagJC. Relationship between fibromyalgia features and smoking. Scand J Rheumatol. 2002;31(5):301-305.
20.
YanmazMNMertMKorkmazM. The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int. 2012;32(4):871-874.
21.
ThomasCVerzaCSFassinaGFusinatoPTForceliniCM. Prevalence of fi bromyalgia in a Brazilian series of patients with multiple sclerosis Prevalência de fi bromialgia em uma série brasileira de pacientes com esclerose múltipla. Arq Neuropsiquiatr. 2023;81(9):803-808.
22.
WolfeFClauwDJFitzcharlesMA, et al.Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113-1122.
SuleimanKHYatesBC. Translating the insomnia severity index into Arabic. J Nurs Scholarsh. 2011;43(1):49-53.
25.
AlzabibiMAShibaniMAlsulimanT, et al.Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus. Syria. BMC Rheumatol [Internet]. 2022;6(1):4-11. Available from: DOI: 10.1186/s41927-022-00294-8.
26.
MarrieRAHorwitzRCutterGTyryTCampagnoloDVollmerT. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler J. 2008;14(8):1091-1098.
27.
HortonMRudickRAHara-CleaverCMarrieRA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010;35(2):83-90.
28.
ZhangYLiangDJiangR, et al.Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample. Clin Rheumatol. 2018;37(2):527-537.
29.
WalittBNahinRLKatzRSBergmanMJWolfeF. The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. PLoS One. 2015;10(9):1-16.
30.
KirmayerLJSartoriusN. Cultural models and somatic syndromes. Psychosom Med. 2007;69(9):832-840.
31.
GammohOSAl-SmadiATayfurM, et al.Syrian female war refugees: preliminary fibromyalgia and insomnia screening and treatment trends. Int J Psychiatry Clin Pract. 2020;24(4):387-391.
32.
HäuserWWolfeFTölleTÜçeylerNSommerC. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26:297-307.
33.
WolfeFClauwDJFitzcharlesMA, et al.The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600-610.
